fluorodeoxyglucose f18 has been researched along with Prodromal Characteristics in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 17 (73.91) | 24.3611 |
| 2020's | 6 (26.09) | 2.80 |
| Authors | Studies |
|---|---|
| Leenders, KL; Meles, SK; Oertel, WH | 1 |
| Albensi, BC; Beheshti, I; Geddert, N; Gupta, V; Ko, JH; Perron, J | 1 |
| Hershey, LA; Lichter, DG | 1 |
| Blommaert, J; Ceccarini, J; Chiò, A; De Schaepdryver, M; De Vocht, J; Devrome, M; Dupont, P; Koole, M; Lamaire, N; Mertens, N; Pagani, M; Poesen, K; Radwan, A; Rezaei, A; Schramm, G; Stam, D; van Aalst, J; Van Damme, P; van den Berg, LH; Van den Stock, J; van Es, MA; Van Esch, H; Van Laere, K; Van Weehaeghe, D; Vandenberghe, R; Vandenbulcke, M; Verhaegen, M | 1 |
| Raji, CA; Silverman, DHS; Torosyan, N | 1 |
| Chen, K; Chen, Y; Cui, C; Gao, R; Jing, D; Liang, Z; Lu, H; Wang, L; Wu, L | 1 |
| Alexopoulos, P; Perneczky, R; Robb, C; Schöpe, J; Udeh-Momoh, C; Wagenpfeil, S | 1 |
| Ba, M; Benedet, AL; Chung, CO; Gauthier, S; Kandiah, N; Kang, MS; Li, X; Mathotaarachchi, S; Ng, KP; Pascoal, TA; Rosa-Neto, P; Shin, M | 1 |
| Dillen, KNH; Fink, GR; Jacobs, HIL; Kukolja, J; Langen, KJ; Onur, ÖA; Richter, N; von Reutern, B | 1 |
| Hatano, K; Hirakawa, H; Ishii, N; Kohno, K; Mizokami, Y; Terao, T | 1 |
| Arbizu, J; Boada, M; Martínez-Lage, P; Monleón, I; Munuera, J; Pérez-Grijalba, V; Pesini, P; Romero, J; Ruiz, A; San-José, I; Sarasa, L; Sarasa, M; Tárraga, L | 1 |
| Arnaldi, D; Bauckneht, M; Brugnolo, A; Chincarini, A; De Carli, F; Didic, M; Dottorini, ME; Drzezga, A; Frisoni, GB; Galluzzi, S; Grazzini, M; Guedj, E; Jonsson, C; Massa, F; Mecocci, P; Morbelli, S; Nobili, F; Ossenkoppele, R; Pagani, M; Pardini, M; Perneczky, R; Sambuceti, G; van Berckel, BNM | 1 |
| Bakardjian, H; Corsi, MC; De Vico Fallani, F; Diego Sitt, J; Dubois, B; Epelbaum, S; Gagliardi, G; Gaubert, S; Habert, MO; Hermann, B; Houot, M; Naccache, L; Oudiette, D; Raimondo, F | 1 |
| Chiba, Y; Fujishiro, H; Iseki, E; Kasanuki, K; Murayama, N; Ota, K; Sato, K | 1 |
| Abbate, C; Arosio, B; Chiara, LR; Deriz, M; Fenoglio, C; Ferri, E; Galimberti, D; Gussago, C; Mari, D; Nicolini, P; Rossi, PD; Scarpini, E; Serpente, M | 1 |
| Adjouadi, M; Barker, W; Cabrerizo, M; Duara, R; Goryawala, M; Loewenstein, D; Zhou, Q | 1 |
| Behr, J; Boehme, R; Buchert, R; Deserno, L; Gleich, T; Heinz, A; Katthagen, T; Pankow, A; Roiser, JP; Schlagenhauf, F | 1 |
| Eustache, P; Nemmi, F; Pariente, J; Péran, P; Saint-Aubert, L | 1 |
| Dichgans, M; Duering, M; Ewers, M; Franzmeier, N; Weiner, M | 1 |
| Cai, W; Feng, DD; Fulham, M; Lu, S; Xia, Y | 1 |
| Alegret, M; Arbizu, J; Becker, JT; Boada, M; Buendía, M; Espinosa, A; Giménez, J; Hendrix, SB; Hernández, I; Ibarria, M; Lafuente, A; Landau, SM; Martínez-Lage, P; Munuera, J; Pesini, P; Pujadas, F; Ruiz, A; Ruiz, S; San José, I; Sarasa, M; Sotolongo-Grau, O; Tárraga, L; Tejero, MA; Valero, S | 1 |
| Crane, PK; DeCarli, C; Glymour, MM; Habeck, C; Kim, S; Lee, GJ; Mormino, E; Mukherjee, S; Nho, K; Risacher, S; Saykin, AJ | 1 |
| Essig, M; Giesel, F; Guenther, T; Haberkorn, U; Henze, R; Küntzelmann, A; Schönknecht, P; Schröder, J; Schroeter, ML | 1 |
2 review(s) available for fluorodeoxyglucose f18 and Prodromal Characteristics
| Article | Year |
|---|---|
Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease.
Topics: Animals; Biomarkers; Brain; Cerebrovascular Circulation; Diagnostic Imaging; Disease Management; Disease Susceptibility; Dopamine; Energy Metabolism; Fluorodeoxyglucose F18; Gene Expression Regulation; Genetic Predisposition to Disease; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Neurotransmitter Agents; Parkinson Disease; Positron-Emission Tomography; Prodromal Symptoms; Severity of Illness Index | 2021 |
Optimizing Use of Neuroimaging Tools in Evaluation of Prodromal Alzheimer's Disease and Related Disorders.
Topics: Alzheimer Disease; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Neuroimaging; Positron-Emission Tomography; Prodromal Symptoms | 2020 |
21 other study(ies) available for fluorodeoxyglucose f18 and Prodromal Characteristics
| Article | Year |
|---|---|
Monitoring Alzheimer's Disease Progression in Mild Cognitive Impairment Stage Using Machine Learning-Based FDG-PET Classification Methods.
Topics: Alzheimer Disease; Cognitive Dysfunction; Disease Progression; Fluorodeoxyglucose F18; Humans; Machine Learning; Prodromal Symptoms | 2022 |
Proposal to Add FDG-PET as an Outcome Measure for Clinical Trials in Patients With Prodromal Lewy Body Dementia.
Topics: Alzheimer Disease; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Outcome Assessment, Health Care; Positron-Emission Tomography; Prodromal Symptoms | 2023 |
Use of Multimodal Imaging and Clinical Biomarkers in Presymptomatic Carriers of C9orf72 Repeat Expansion.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Biomarkers; C9orf72 Protein; Case-Control Studies; Cerebral Cortex; DNA Repeat Expansion; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Heterozygote; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prodromal Symptoms; Prospective Studies | 2020 |
Metabolic Changes Detected by 18F-FDG PET in the Preclinical Stage of Familial Creutzfeldt-Jakob Disease.
Topics: Adult; Aged; Brain; Creutzfeldt-Jakob Syndrome; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pedigree; Positron-Emission Tomography; Prodromal Symptoms; Young Adult | 2020 |
Biomarkers and Functional Decline in Prodromal Alzheimer's Disease.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Prodromal Symptoms; Time Factors | 2017 |
Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease.
Topics: Aged; Alzheimer Disease; Aniline Compounds; Apolipoprotein E4; Biomarkers; Brain; Brain Mapping; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Irritable Mood; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Positron-Emission Tomography; Prodromal Symptoms; Prognosis; Radiopharmaceuticals; Sleep; tau Proteins | 2017 |
Functional Disintegration of the Default Mode Network in Prodromal Alzheimer's Disease.
Topics: Aged; Alzheimer Disease; Analysis of Variance; Cognition Disorders; Female; Fluorodeoxyglucose F18; Functional Laterality; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Models, Neurological; Neural Pathways; Neuropsychological Tests; Oxygen; Positron-Emission Tomography; Prodromal Symptoms; Psychiatric Status Rating Scales; Surveys and Questionnaires | 2017 |
Cyclothymic temperament and glucose metabolism in the right superior parietal lobule.
Topics: Adult; Bipolar Disorder; Brain; Cyclothymic Disorder; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Parietal Lobe; Positron-Emission Tomography; Prodromal Symptoms; Radiopharmaceuticals; Temperament; Young Adult | 2017 |
Plasma Aβ42/40 Ratio Detects Early Stages of Alzheimer's Disease and Correlates with CSF and Neuroimaging Biomarkers in the AB255 Study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Apolipoproteins E; Biomarkers; Case-Control Studies; Cognitive Dysfunction; Cross-Sectional Studies; Early Diagnosis; Female; Fluorodeoxyglucose F18; Genotype; Humans; Male; Neuroimaging; Peptide Fragments; Phosphorylation; Plaque, Amyloid; Positron-Emission Tomography; Prodromal Symptoms; tau Proteins; Thiazoles | 2019 |
Head-to-Head Comparison among Semi-Quantification Tools of Brain FDG-PET to Aid the Diagnosis of Prodromal Alzheimer's Disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Disease Progression; Early Diagnosis; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Prodromal Symptoms; Support Vector Machine | 2019 |
EEG evidence of compensatory mechanisms in preclinical Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Biomarkers; Brain Waves; Case-Control Studies; Disease Progression; Electroencephalography; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Nerve Degeneration; Positron-Emission Tomography; Prodromal Symptoms | 2019 |
A follow up study of non-demented patients with primary visual cortical hypometabolism: prodromal dementia with Lewy bodies.
Topics: Aged; Aged, 80 and over; Early Diagnosis; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Functional Neuroimaging; Glucose; Humans; Lewy Body Disease; Male; Middle Aged; Prodromal Symptoms; Prognosis; Radionuclide Imaging; Visual Cortex; Wechsler Scales | 2013 |
Phenotypic variability associated with the C9ORF72 hexanucleotide repeat expansion: a sporadic case of frontotemporal lobar degeneration with prodromal hyposmia and predominant semantic deficits.
Topics: Aged; C9orf72 Protein; DNA Repeat Expansion; Fluorodeoxyglucose F18; Frontotemporal Lobar Degeneration; Humans; Hypoxia; Male; Memory Disorders; Positron-Emission Tomography; Prodromal Symptoms; Proteins | 2014 |
Multivariate analysis of structural MRI and PET (FDG and 18F-AV-45) for Alzheimer's disease and its prodromal stages.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Case-Control Studies; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Least-Squares Analysis; Magnetic Resonance Imaging; Male; Multivariate Analysis; Positron-Emission Tomography; Prodromal Symptoms | 2014 |
Aberrant Salience Is Related to Reduced Reinforcement Learning Signals and Elevated Dopamine Synthesis Capacity in Healthy Adults.
Topics: Adolescent; Adult; Conditioning, Operant; Corpus Striatum; Dopamine; Dopamine Agents; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Levodopa; Magnetic Resonance Imaging; Male; Oxygen; Positron-Emission Tomography; Prodromal Symptoms; Psychotic Disorders; Reaction Time; Reinforcement, Psychology; Young Adult | 2015 |
Multimodal Magnetic Resonance Imaging in Alzheimer's Disease Patients at Prodromal Stage.
Topics: Aged; Alzheimer Disease; Biomarkers; Brain; Cognitive Dysfunction; Diffusion Tensor Imaging; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Mental Status Schedule; Multimodal Imaging; Neuropsychological Tests; Organ Size; Positron-Emission Tomography; Prodromal Symptoms; Radiopharmaceuticals | 2016 |
Left frontal cortex connectivity underlies cognitive reserve in prodromal Alzheimer disease.
Topics: Alzheimer Disease; Chi-Square Distribution; Cognition Disorders; Cognitive Reserve; Epilepsy; Female; Fluorodeoxyglucose F18; Frontal Lobe; Functional Laterality; Humans; Magnetic Resonance Imaging; Male; Nerve Net; Neuropsychological Tests; Oxygen; Positron-Emission Tomography; Prodromal Symptoms | 2017 |
Early identification of mild cognitive impairment using incomplete random forest-robust support vector machine and FDG-PET imaging.
Topics: Aged; Alzheimer Disease; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Prodromal Symptoms; Support Vector Machine; Uncertainty | 2017 |
Cognitive Composites Domain Scores Related to Neuroimaging Biomarkers within Probable-Amnestic Mild Cognitive Impairment-Storage Subtype.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Mental Recall; Neuroimaging; Neuropsychological Tests; Organ Size; Positron-Emission Tomography; Prodromal Symptoms; Radiopharmaceuticals; Survival Analysis; Thiazoles | 2017 |
Relationship between baseline brain metabolism measured using [¹⁸F]FDG PET and memory and executive function in prodromal and early Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Brain; Cognition Disorders; Early Diagnosis; Executive Function; Female; Fluorodeoxyglucose F18; Humans; Male; Memory; Memory Disorders; Positron-Emission Tomography; Prodromal Symptoms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Tissue Distribution | 2012 |
Impaired cerebral glucose metabolism in prodromal Alzheimer's disease differs by regional intensity normalization.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Case-Control Studies; Cerebellum; Cognition Disorders; Female; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Gyrus Cinguli; Humans; Male; Middle Aged; Parietal Lobe; Positron-Emission Tomography; Prodromal Symptoms; Radiopharmaceuticals; Temporal Lobe | 2013 |